AUVIQ — Applied UV Income Statement
0.000.00%
- $0.00m
- $8.41m
- $40.72m
- 32
- 86
- 36
- 50
Annual income statement for Applied UV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9.1 | 5.73 | 11.7 | 20.1 | 40.7 |
Cost of Revenue | |||||
Gross Profit | 3.09 | 1.01 | 4.1 | 4.04 | 7.83 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.41 | 9.05 | 18.7 | 36.5 | 52.4 |
Operating Profit | 2.69 | -3.31 | -7 | -16.4 | -11.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.67 | -3.3 | -7.48 | -16.6 | -13.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.57 | -3.37 | -7.39 | -16.6 | -13.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.57 | -3.37 | -7.39 | -16.6 | -13.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.57 | -3.37 | -7.99 | -18 | -14.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 27.5 | -73.8 | -110 | -125 | -43.7 |
Dividends per Share |